Effects of oral anticoagulant therapy in patients with pulmonary diseases

BACKGROUND: To evaluate the effect of oral anticoagulants (OACs) therapy, including vitamin K antagonist (VKA) and direct oral anticoagulants (DOAC) in patients with pulmonary diseases. METHODS: Literature from PubMed, MEDLINE, and Cochrane Library were screened until June 2022. Studies assessing OA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Jiying, Feng, Shenghui, Xu, Shuo, Liu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399807/
https://www.ncbi.nlm.nih.gov/pubmed/36035947
http://dx.doi.org/10.3389/fcvm.2022.987652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399807/
https://www.ncbi.nlm.nih.gov/pubmed/36035947
http://dx.doi.org/10.3389/fcvm.2022.987652

Ejemplares similares